SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2019 / Cilt: 28 - Sayı: 3

Ileal Neuroendocrin Tumor Metastasis to Breast Diagnosed with Ga-68 DOTATATE PET/CT

Ga-68 DOTATATE PET/BT ile Tespit Edilen İleal Nöroendokrin Tümör Meme Metastazı

Sevda SAĞLAMPINAR KARYAĞAR
Savaş KARYAĞAR
Osman GÜVEN
Pages
129–131
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The histopathologic findings obtained by tru-cut biopsy revealedWDNET metastasis (Ki-67 proliferation index 1%).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast metastasis of the well differentiated neuroendocrin tumor (WDNET) of the ileum is very rare.
📊
Key Findings & Data:A case of a 62-year-old woman withileal WDNET, who underwent restaging with Ga-68 DOTATATE PET/CT due to progression of metastatic lesions under the treatment withsomatostatin analog and mammalian target of rapamycin inhibitors.
💡
Conclusion & Impact:The histopathologic findings obtained by tru-cut biopsy revealedWDNET metastasis (Ki-67 proliferation index 1%).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Breast metastasis of the well differentiated neuroendocrin tumor (WDNET) of the ileum is very rare. A case of a 62-year-old woman withileal WDNET, who underwent restaging with Ga-68 DOTATATE PET/CT due to progression of metastatic lesions under the treatment withsomatostatin analog and mammalian target of rapamycin inhibitors. Ga-68 DOTATATE PET/CT demonstrated intense increased uptake in thesubsantimetric nodular lesion in the upper outer quadrant of the left breast. The histopathologic findings obtained by tru-cut biopsy revealedWDNET metastasis (Ki-67 proliferation index 1%).

Özet

İyi diferansiye ileal nöroendokrin tümör (NET) meme metastazı oldukça nadirdir. Altmış iki yaşında iyi diferansiye NET tümör tanılı kadın hastaya, metastatik lezyonlarının somatostatin analoğu ve rapamisinin memeli hedefi inhibitörleri ile tedavi görmekte iken progrese olması nedeniyle yeniden evreleme amacıyla Ga-68 DOTATATE PET/BT görüntüleme yapıldı. Ga-68 DOTATATE PET/BT görüntülemede, sol meme üst dış kadrandaki subsantimetrik nodüler lezyonda yoğun artmış aktivite tutulumu izlendi. Lezyondan yapılan tru-cut biyopsinin histopatolojik incelemesinde iyi diferansiye NET metastazı olduğu tespit edildi (Ki-67 proliferasyon indeksi %1).

🔖

Cite This Article

KARYAĞAR, S. S., KARYAĞAR, S., GÜVEN, O. (2022). Ileal Neuroendocrin Tumor Metastasis to Breast Diagnosed with Ga-68 DOTATATE PET/CT. Molecular Imaging and Radionuclide Therapy, Cilt: 28 - Sayı: 3, 129–131. https://ajindex.com/articles/581600

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Subramaniam RM, Bradshaw LM, Lewis K, Pinho D, Shah C, Walker RC. ACR Practice parameter for the performance of Gallium-68 DOTATATE PET/CT for neuroendocrin tumors. Clin Nucl Med 2018;43:899-908
  2. Modlin IM, Lye KD, Kidd M. A 5 decade analysis of 13,715 carcinoid tumors. Cancer 2003;15:934-959
  3. Clark BZ, Bhargava R. Metastatic neuoroendocrin tumors to the breast: Diagnostic pitfall with significant clinical implications. AJSP 2017;22:269- 274
  4. Dervishac OA, Renzi AS, Genato R, Xiao PQ, Asarian AP. Neuroendocrin tumor of the breast:is it primary or metastatic? Int J Case Rep Images 2016;7:34-39
  5. Ahn S, Bhagwandin S, Reindl B, Jaffer S, Bickell N, Labow DM, Scmidt H. Metastatic carcinoid tumor presenting as a breast mass: A case report and review of the literature. Arch Surg Oncol 2016;2:1-5
  6. Policeni F, Pakalniskis B, Yang L. Occult primary neuroendocrin tumor metastasis to breast detected on screeniig mammogram. J Clin Imaging Sci 2016;6:41.